Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine
about
The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis BAntiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusClinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.Low dynamic state of viral competition in a chronic avian hepadnavirus infection.The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infectionCombination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.Mutations of the woodchuck hepatitis virus polymerase gene that confer resistance to lamivudine and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.Superinfection with woodchuck hepatitis virus strain WHVNY of livers chronically infected with strain WHV7Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.Capacity of a natural strain of woodchuck hepatitis virus, WHVNY, to induce acute infection in naive adult woodchucks.Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.Antiviral resistance and hepatitis B therapy.The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.Viral resistance in hepatitis B: prevalence and management.Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection.
P2860
Q27007019-6BC01068-671D-40AD-8F8F-AB4BFA8ED12FQ28360714-D1EC7FE8-9DD8-4ED4-8380-4508E8B8B880Q33206221-BDCC45F6-2094-441C-A266-8E07A23A5A1FQ33787127-EEC4328C-4B4D-4E5D-BF80-9918F9B75F7BQ33787525-D2388B09-2A40-43F5-B7C8-2E278E6C605AQ33812799-4915383C-3919-4C2F-BC8F-18FE3B552827Q33834863-CCE81398-4ABB-4B77-9934-F36D28A5719AQ34330228-21742D94-2DD3-4E88-B496-8C593B3F573CQ34992624-6EC2CF24-7415-422F-8435-01F881DCBD25Q35014297-DAAD5821-6331-4323-92E6-E5C3BE23F1BDQ35166065-91CD3920-383A-4CD2-BC49-C6199862D0E6Q35751930-C2137037-3688-4A38-B50F-89A864726FABQ36932959-81CDF6BF-269A-4136-9775-A449B4C5C912Q37255008-4082E2AD-AC98-42F9-8D8B-3404665EDC5FQ38618869-DA98E8A0-E9E8-4EF7-A729-07EAB026493CQ39429039-A8171CBC-D6BD-4D15-84C9-0B089CF7E3BCQ40847895-5DE2A46A-35EA-4245-8D5B-3857132BE470
P2860
Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@ast
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@en
type
label
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@ast
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@en
prefLabel
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@ast
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@en
P2093
P2860
P1476
Emergence of drug-resistant po ...... ntiviral nucleoside lamivudine
@en
P2093
C E Aldrich
J Saputelli
L D Condreay
M Deslauriers
P2860
P304
P407
P577
1999-08-01T00:00:00Z